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Summary
Objective: Activated synoviocytes play important roles in the progression of human osteoarthritis (OA). Intra-articular injection of high
molecular weight hyaluronic acid (HMW-HA) has been used as viscosupplementation for knee OA but its effect on synoviocytes remains un-
disclosed. This study aims to investigate the effects of HMW-HA on the gene expression of 16 OA-associated cytokines and enzymes, includ-
ing interleukin (IL)-1b, IL-6, IL-8, leukemia inhibitory factor (LIF), tumor necrosis factor (TNF)-a, TNF-a converting enzyme (TACE), matrix
metalloproteinase (MMP)-1, MMP-2, MMP-3, MMP-9, MMP-13, tissue inhibitor of metalloproteinase (TIMP)-1, TIMP-2, aggrecanase-1, aggre-
canase-2, and inducible nitric oxide synthase (iNOS), in ﬁbroblast-like synoviocytes (FLS) from patients with early stage OA.
Method: Synovial ﬂuid-derived FLS were obtained from the knees of 15 patients with early stage OA. IL-1-stimulated or unstimulated FLS
were cultured with or without the treatment of 600e800 kDa HMW-HA. Moreover, blocking experiments with anti-CD44 monoclonal antibodies
(mAb) were used to examine the involvement of CD44 in HMW-HA effects. We designed and validated the real-time quantitative polymerase
chain reaction (Q-PCR) assays with SYBR Green dyes for simultaneous quantiﬁcation of the expression of the 16 genes.
Results: HMW-HA down-regulated IL-8 and iNOS gene expression in unstimulated FLS and down-regulated aggrecanase-2 and TNF-a gene
expression in IL-1-stimulated FLS. CD44 blocking inhibited the down-regulatory effects of HMW-HA on gene expression.
Conclusion: HMW-HA may have a structure-modifying effect for OA by down-regulation of aggrecanase-2 in FLS. HMW-HA also has an anti-
inﬂammatory effect by down-regulation of TNF-a, IL-8, and iNOS in FLS. These effects may be mediated through the interaction of CD44 and
HMW-HA.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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SocietyIntroduction
Recent studies suggest that osteoarthritis (OA) is a ‘‘non-
classical’’ inﬂammatory disease1,2 and that activated
synoviocytes play important roles in the progression of
human OA3,4. Synoviocytes can produce various OA-asso-
ciated cytokines and enzymes, such as interleukin (IL)-1b,
IL-6, IL-8, leukemia inhibitory factor (LIF), tumor necrosis
factor (TNF)-a, TNF-a converting enzyme (TACE), matrix
metalloproteinase (MMP)-1, MMP-2, MMP-3, MMP-9,
MMP-13, tissue inhibitor of metalloproteinase (TIMP)-1,
TIMP-2, aggrecanase-1, aggrecanase-2, and inducible
nitric oxide synthase (iNOS)5e11. In addition, a recent study
showed that ﬁbroblast-like synoviocytes (FLS) can be
obtained from synovial ﬂuid, and the phenotype and func-
tion of synovial ﬂuid-derived FLS are the same as those
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Received 2 February 2006; revision accepted 10 May 2006.123derived from the synovium of surgical specimens12. This
cell model makes it possible to study the FLS from the pa-
tients with early stage OA, whose tissue specimens are sel-
dom available.
Hyaluronic acid (HA), a core component of extracellular
matrix, comprises a repeat of N-acetylglucosamine and
D-glucuronic acid. HA has been identiﬁed as an important
modulator in many physiological and pathological pro-
cesses13,14. Most of these responses are mediated through
HAeCD44 interaction. Moreover, HA is a critical constituent
component of normal synovial ﬂuid and an important
contributor to joint homeostasis15. In OA, both the concen-
tration and molecular weight of intra-articular endogenous
HA are decreased16. In clinical practice, intra-articular injec-
tion of high molecular weight HA (HMW-HA) has been used
as viscosupplementation for knee OA and its therapeutic ef-
ﬁcacy has been veriﬁed17. However, the exact mechanism
of HMW-HA in treating OA remains partially disclosed. Only
a few studies examine the effects of HMW-HA on synovio-
cytes18e20. Sasaki et al. found that HMW-HA inhibited the
IL-1-induced expression of MMP-1 and MMP-3 in human
synovial cells19. Takahashi et al. found that intra-articular
injection of HMW-HA suppressed the mRNA expression7
1238 C.-T. Wang et al.: HA decreases cytokine and enzyme in FLSFig. 1. Phenotypic features of synovial ﬂuid-derived FLS (passages 4 through 6). (A) Light microscopy showed that FLS were homogeneous
and spindle-shaped in morphology. (B) Flow cytometric analysis showed that more than 90% of FLS were positively stained with anti-ﬁbroblast
surface molecule mAb D7-FIB. (C) Immunocytochemistry revealed that the majority of FLS were positively stained with anti-prolyl-4-hydrox-
ylase mAb 5B5. (D) Immunocytochemistry of negative control staining using isotype-matched control IgG did not display a positive reaction.of MMP-3 and IL-1b in the synovium of rabbit OA model20.
Qiu et al. found that intra-articular injection of HMW-HA
decreased the mRNA expression of MMP-3 in the synovium
of rabbit OA model18. Therefore, more studies are needed
to fully elucidate the effects of HMW-HA on synoviocytes.
Reverse transcription (RT) followed by polymerase chain
reaction (PCR) is the technique of choice for analyzing
geneexpressiondue to its highsensitivity. Among the various
methods of quantiﬁcation for RT-PCR, real-time quantitative
PCR (Q-PCR) has advantages of extremely wide dynamic
detection range and of higher reliability of results compared
with end-point determinations using conventional PCR21.
Real-time Q-PCR can quantify DNA fragment ampliﬁcation
using Taqman probes or SYBR Green ﬂuorescence. SYBR
Green is less expensive than Taqman probes and can pro-
vide an equally accurate result in real-time Q-PCR if the
PCRspeciﬁcity is highand the artifacts suchasprimer dimers
are minimal22, thus becoming an valuable and economical
tool in researching gene expression.
The aims of this study were to investigate the effects of
HMW-HA on the gene expression of 16 OA-associated
cytokines and enzymes, including IL-1b, IL-6, IL-8, LIF,
TNF-a, TACE, MMP-1, MMP-2, MMP-3, MMP-9, MMP-13,
TIMP-1, TIMP-2, aggrecanase-1, aggrecanase-2 and
iNOS, in synovial ﬂuid-derived FLS from the patients with
early stage OA. Furthermore, we also examine the involve-
ment of CD44, a major HA-binding receptor, in these
effects. These may clarify the mechanism of HMW-HA in
treating OA. In this study, we designed and validated the
real-time Q-PCR assays with SYBR Green dye for simulta-
neous quantiﬁcation of the expression of these 16 genes.Methods
CULTURES OF SYNOVIAL FLUID-DERIVED FLS
The study protocol was approved by the Institutional
Review Board of the National Taiwan University Hospital.
Synovial ﬂuid was aspirated from the knees of 15 patients
with early stage OA (KellgreneLawrence grades I and II).
The synovial ﬂuid was centrifuged at 450g for 30 min, cell
pellets were resuspended in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) (Gibco, Grand Island, NY, USA) contain-
ing 10% fetal calf serum (FCS), and incubated for 24 h at
37(C in a plastic culture ﬂask. Non-adherent cells were
washed out and medium was changed daily for the next 3
days. The remaining adherent cells were cultured for addi-
tional 2 weeks in a ﬂask before trypsinization, and then
passed to new culture ﬂasks. Cell passages 4 through 6
were FLS, which were used for phenotypic analysis and
for experiments.
PHENOTYPIC ANALYSIS OF SYNOVIAL FLUID-DERIVED FLS
For surface marker staining, the anti-ﬁbroblast surface
molecule monoclonal antibodies (mAb) (clone D7-FIB;
Abcam, Cambridge, UK) were used. FLS (passages 4
through 6) were released from culture by trypsinization,
washed once, and resuspended in DMEM containing 1%
FCS. Cells were incubated with the primary antibodies
D7-FIB at 4(C for 30 min. After three washes, the cells
were incubated with ﬂuorescein isothiocyanate (FITC)-con-
jugated goat anti-mouse IgG mAb (Serotec, Oxford, UK) as
secondary antibodies at 4(C for 30 min and then washed
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Primer sequences and product sizes in quantitative PCR
Target gene Forward primer (50e30) Reverse primer (50e30) Genomic
DNA product
size (bp)
cDNA product
size (bp)
GenBank
accession
number
18S rRNA* AAGGAGACTCTGGCATGCTAAC CAGACATCTAAGGGCATCACAGAC 133 133 NG_002801
HPRT1* CCCTGGCGTCGTGATTAGT GTGATGGCCTCCCATCTCCTT 0 169 NM_000194
MMP-1 CATGCCATTGAGAAAGCCTTCC AGAGTTGTCCCGATGATCTCC 0 123 NM_002421
MMP-2 TGCTGGAGACAAATTCTGGA
GATAC
ACTTCACGCTCTTCAGACTTTGG 0 200 NM_004530
MMP-3 GACAAAGGATACAACAGGG
ACCAAT
TGAGTGAGTGATAGAGTGGGTACAT 0 122 NM_002422
MMP-9 TGCCCGGACCAAGGATACAG TCAGGGCGAGGACCATAGAG 0 182 NM_004994
MMP-13 GTCTCTCTATGGTCCAGGA
GATGAA
AGGCGCCAGAAGAATCTGT 0 144 NM_002427
TIMP-1 CCCAGAGAGACACCAGAGAAC CACGAACTTGGCCCTGATGAC 0 167 NM_003254
TIMP-2 GCACATCACCCTCTGTGACTT AGCGCGTGATCTTGCACT 0 110 NM_003255
Aggrecanase-1 ATGGCTATGGGCACTGTCTC GTGTTTGGTCTGGCACATGG 0 206 NM_005099
Aggrecanase-2 CCTGCCCACCCAATGGTAAATC CGGCCTACATTCAGTGCCATC 0 218 NM_007038
IL-1b GGCTTATTACAGTGGCAATGAGGA TCCATGGCCACAACAACTGA 0 180 NM_000576
IL-6 GACAGCCACTCACCTCTTCA TTCACCAGGCAAGTCTCCTC 0 211 NM_000600
IL-8 CTGCGCCAACACAGAAATT
ATTGTA
TTCACTGGCATCTTCACTGATTCTT 0 170 NM_000584
LIF ATACGCCACCCATGTCACAA CCCTGGGCTGTGTAATAGAGAA 0 107 NM_002309
TNF-a CCCAGGCAGTCAGATCATCTT TCTCAGCTCCACGCCATT 0 140 NM_000594
TACE GTGACATGAATGGCAAAT
GTGAGA
ACAATGGACAAGAATGCTGAAAGG 0 176 NM_003183
iNOS TCACCAGGAGATGCTGAACTAC GAGCACAGCTTTGACCAAGAC 0 142 NM_000625
bp¼ base pairs; rRNA¼ ribosomal RNA; HPRT1¼ hypoxanthine phosphoribosyltransferase 1; MMP¼matrix metalloproteinase;
TIMP¼ tissue inhibitor of metalloproteinase; IL¼ interleukin; LIF¼ leukemia inhibitory factor; TNF¼ tumor necrosis factor; TACE¼ TNF-a
converting enzyme; and iNOS¼ inducible nitric oxide synthase.
*18S rRNA and HPRT1 are internal control genes for normalization in relative quantiﬁcation of gene expression.three times. Subsequently, the cells were ﬁxed in a 1.25%
paraformaldehyde solution and then analyzed using
a FACS Calibur ﬂow cytometer (BD Biosciences, San Jose,
CA, USA). The positive and negative populations were
determined according to the staining of unreactive isotype-
matched control IgG.
For immunocytochemistry staining, the anti-ﬁbroblast
prolyl-4-hydroxylase mAb (clone 5B5; Abcam, Cambridge,
UK) were used. FLS (passages 4 through 6) in 6-well
culture plates were ﬁxed with acetone for 15 min, washed
twice with phosphate-buffered saline (PBS), then incubated
with 1% bovine serum albumin (BSA) for 30 min and with
the primary antibodies 5B5 for 1 h in a humid chamber at
4(C. After three washes with PBS, the cells were stained
with VECTASTAIN Universal Quick Kit (Vector Laboratories
Inc., Burlingame, CA, USA) according to the manufacturer’s
protocol. Unreactive isotype-matched control IgG was used
as primary antibodies for negative controls.
CELL STIMULATION AND TREATMENT
For all of the experiments, FLS were plated in 6-well cul-
ture plates and serum starved for 24 h in DMEM containing
1% FCS to synchronize cells in a non-activating and non-
proliferating phase. FLS were then cultured in DMEM
containing 10% FCS and either (1) maintained as unstimu-
lated and untreated controls, (2) treated with 100 mg/ml
HMW-HA of MW 600e800 kDa (Artzdispo, Seikagaku
Inc., Japan) for 24 h, (3) stimulated with 1 ng/ml IL-1 (Pepro-
Tech, Rocky Hill, NJ, USA) for 24 h, or (4) stimulated with
1 ng/ml IL-1 and treated with 100 mg/ml HMW-HA for 24 h.
In the CD44 blocking experiments, FLS were cultured in
DMEM containing 10% FCS and either (1) stimulated with
1 ng/ml IL-1 for 24 h, (2) stimulated with 1 ng/ml IL-1 and
treated with 100 mg/ml HMW-HA for 24 h, or (3) stimulated
with 1 ng/ml IL-1 and treated with 100 mg/ml HMW-HA for24 h after pretreatment with 20 mg/ml anti-CD44 blocking
mAb (clone 5F12; Lab Vision Corp., Fremont, CA, USA)
or 20 mg/ml isotype-matched control IgG (eBioscience,
San Diego, CA, USA) for 1 h. The optimal concentration
of HMW-HA (100 mg/ml) used in this study was determined
according to the results of a preliminary doseeresponse
study using 10 mg/ml, 100 mg/ml, or 1 mg/ml HMW-HA to
treat the FLS from ﬁve patients (Fig. 5).
TOTAL RNA ISOLATION, QUANTIFICATION AND RT
FLS after treatments were lysed and total RNA was
extracted with Trizol agent (Life Technologies, Rockville,
MD, USA) according to the manufacturer’s protocol. Total
RNA was quantiﬁed by spectrophotometry. DNase diges-
tion was carried out using DNA-free (Ambion Inc., Austin,
TX, USA) as per the manufacturer’s protocol. One micro-
gram of total RNA was converted to cDNA using the Super-
script II reverse transcriptase (Invitrogen, Carlsbad, CA,
USA). For each reaction, 4 mL 5 ﬁrst-strand buffer
(50 mM TriseHCl, pH 8.3, 375 mM KCl, 15 mM MgCl2),
2 mL of 0.1 M dTT, 5 U RNAsin, 500 mM dNTP mix,
200 pmol Oligo-dT, 25 U Superscript II reverse transcrip-
tase and sterile water were added to the RNA to a volume
of 20 mL. This reaction was then incubated at 42(C for 1 h.
The ﬁnished cDNA products were stored in aliquots
at 80(C until needed.
PRIMER DESIGN AND REAL-TIME Q-PCR ASSAYS
The mRNA sequences were retrieved from the NCBI
website. The NCBI BLAST server23 was used to determine
primer speciﬁcity, where reported similarities above 75% to
non-speciﬁc sites within the human genome were undesir-
able. Primers were designed to span the exoneexon bound-
ary to eliminate the possible inﬂuence of the contamination
1240 C.-T. Wang et al.: HA decreases cytokine and enzyme in FLSFig. 2. Melting curve analysis and agarose gel electrophoresis of real-time Q-PCR assays. (A) Melting curve analysis showed a single melting
peak in each real-time Q-PCR assay. (B) Agarose gel electrophoresis also showed a single PCR product in each real-time Q-PCR assay.of genomic DNA. Lengths of PCR products were designed
to range between 100 and 220 bp. Primers were designed
to have a length of 18e25 bp, 40e60% GC content, and
a theoretical annealing temperature of approximately
59(C. Compatible 30 end sequences that may cause primer
dimer formation, of either the primer itself or its primer pair,
were avoided by visual inspection of the candidate primer
sequences. Negative water controls were also prepared
for each primer set.
Platinum SYBR Green qPCR SuperMix (Invitrogen,
Carlsbad, CA, USA) was used in all reactions. The ABI
PRISM 7700 Sequence Detection System (Applied Bio-
systems, Foster City, CA, USA) was used for all real-time
Q-PCRs. The PCR thermal protocol applied consisted of
a 2 min 95(C denaturation step, followed by 45 repeats of
a 15 s 95(C denaturation step, a 30 s 59(C annealing
step and a 30 s extension step at 72(C. A melting curve
analysis was performed after ﬁnal ampliﬁcation period via
a temperature gradient from 60(C to 95(C. All real-time
Q-PCR ampliﬁed products were separated on agarose gel
using the appropriate DNA ladder to conﬁrm appropriate
fragment sizes and lacking of primer dimers.
STANDARD CURVES
Real-time Q-PCRs for the primer sets of 18S ribosomal
RNA (rRNA), hypoxanthine phosphoribosyltransferase 1(HPRT1), IL-1b, IL-6, IL-8, LIF, TNF-a, TACE, MMP-1,
MMP-2, MMP-3, MMP-9, MMP-13, TIMP-1, TIMP-2, aggre-
canase-1, aggrecanase-2 and iNOS were tested for linearity
of response by constructing standard curves. Based on the
methods modiﬁed from the standard curve protocol of Whe-
lan et al.24, 1/10 dilution series of the puriﬁed PCR products
was prepared in nuclease-free water and SYBR Green
Q-PCRwas performed for the primer sets on 102e109 copies
of their corresponding cDNA PCR products as templates.
The target PCR products were puriﬁed by agarose gel elec-
trophoresis. The absolute concentration of the puriﬁed PCR
products was measured by using PicoGreen dsDNA quanti-
tation reagent (Invitrogen, Carlsbad, CA, USA). The copy
numbers of the puriﬁed PCR products were calculated from
the DNA concentration by taking account of the size of
each speciﬁc PCR product, the mean molecular weight of
the nucleotide bases (340.5 g/mol), Avogadro’s number
(6.022 1023), and the volume25.
STATISTICAL ANALYSIS AND RELATIVE QUANTIFICATION
OF GENE EXPRESSION
Relative expression software tool (REST)26 was used to
calculate comparative gene expression levels between
samples after normalization to the control housekeeping
gene (18S rRNA and HPRT1) expression. Using the ABI
PRISM 7700 System software, the threshold cycle, at
1241Osteoarthritis and Cartilage Vol. 14, No. 12Fig. 3. Standard curves and ampliﬁcation efﬁciencies of real-time Q-PCR assays. The standard curves of all real-time Q-PCR assays showed
high linearity over a wide range of starting copy numbers of cDNA templates. The equation represents the relationship of the threshold cycle
value (CT) and the log value of starting copy number of the sample from the dilution series. R
2¼ correlation coefﬁcient; Eff¼ calculated
ampliﬁcation efﬁciency.which the threshold cycle value (CT) was measured, was
adjusted to the exponential phase of the ampliﬁcation
traces. The average of comparative gene expression ratio
was determined from triplicate real-time Q-PCRs to take
variation into account. A standard curve graph of CT vs
log value of starting copy number of the sample from the di-
lution series was constructed. The slope of the standard
curve was used to determine the ampliﬁcation efﬁciency:
Efﬁciency¼ 10(1/slope) 1. If calculated ampliﬁcation efﬁ-
ciency was more than 1, then 100% ampliﬁcation efﬁciency
was assumed. Correlation coefﬁcients were derived from
the standard linear regression. Corrected comparative
gene expression ratio adjusted by ampliﬁcation efﬁciencywas calculated using REST. Pair-wise ﬁxed reallocation
randomization test provided in REST was used to distin-
guish statistically signiﬁcant results. Signiﬁcance was set
at P-value <0.05.
Results
PHENOTYPIC FEATURES OF SYNOVIAL FLUID-DERIVED FLS
FLS (passages 4 through 6) exhibited uniform spindle-
shaped and ﬁbroblast-like morphology [Fig. 1(A)]. The ﬁbro-
blast phenotype of FLS (passages 4 through 6) was
conﬁrmed by analysis of surface antigen and intracellular
1242 C.-T. Wang et al.: HA decreases cytokine and enzyme in FLSFig. 4. Effect of IL-1 (1 ng/ml) stimulation on gene expression in FLS. Values are expressed in fold in comparison with control group after
normalization to housekeeping gene. Data are expressed as mean S.E.M. *P< 0.05.protein. Flow cytometric analysis showed that more than
90% of FLS expressed the ﬁbroblast surface marker
[Fig. 1(B)]. Immunocytochemistry staining revealed the
presence of ﬁbroblast product prolyl-4-hydroxylase in the
majority of FLS [Fig. 1(C)], whereas negative control stain-
ing did not display a positive reaction [Fig. 1(D)].
PRIMER DESIGN AND CONFIRMATION
OF PRIMER SPECIFICITY
Designed primer sequences and expected RT-PCR prod-
uct sizes are listed in Table I. The speciﬁcity of RT-PCR
products was conﬁrmed with the high resolution agarose
gel electrophoresis and a single band of the desired length
was shown [Fig. 2(B)]. In addition, the melting curve analy-
sis was performed. The Q-PCR assay for each gene
showed a single product with a speciﬁc melting temperature
as follows: 18S rRNA, 85.3(C; HPRT1, 79.7(C; MMP-1,
80.9(C; MMP-2, 86.3(C; MMP-3, 81.3(C; MMP-9,
88.2(C; MMP-13, 80.4(C; aggrecanase-1, 89.7(C; aggre-
canse-2, 84.9(C; TIMP-1, 88.1(C; TIMP-2, 86.3(C; IL-1b,
86.8(C; IL-6, 82.3(C; IL-8, 80.5(C; LIF, 83.6(C; TNF-a,
87.3(C; TACE, 78.8(C; and iNOS, 82.2(C [Fig. 2(A)]. No
primer dimers were generated during the applied 45 ampli-
ﬁcation cycles of real-time Q-PCR.
Q-PCR AMPLIFICATION EFFICIENCIES AND LINEARITY
All real-time Q-PCR assays functioned optimally using
Platinum SYBR Green qPCR SuperMix without the addi-
tion of MgCl2 to the reagent. The standard curves of Q-PCR
assays for all the 18 genes had correlation coefﬁcients of
0.98 or higher and the ampliﬁcation efﬁciencies were mostly
beyond 90% in the investigated range from 102 to 109 cop-
ies of cDNA templates (Fig. 3).
DOSE-RESPONSE STUDY
In both the FLS with and without IL-1 stimulation, adding
100 mg/ml HMW-HA obviously decreased the gene expres-
sion levels of most of the 16 OA-associated cytokines and
enzymes. In comparison with 100 mg/ml HMW-HA, 1 mg/mlHMW-HA had no additional down-regulatory effect on gene
expression. On the other hand, 10 mg/ml HMW-HA had no
obvious down-regulatory effect on gene expression (Fig. 5).
Therefore, we used 100 mg/ml HMW-HA to conduct the
following experiments.
HMW-HA down-regulated IL-8 and iNOS gene
expression in non-stimulated FLS
In FLS without IL-1 stimulation, adding HMW-HA de-
creased the expression levels of all the 16 genes. Among
these, adding HMW-HA signiﬁcantly decreased the IL-8
gene expression level to 3.1% (P< 0.05) and signiﬁcantly
decreased the iNOS gene expression level to 7.5%
(P< 0.05) [Fig. 6(A)].
HMW-HA down-regulated aggrecanase-2 and
TNF-a gene expression in IL-1-stimulated FLS
After IL-1 stimulation, the expression levels of 11 genes
signiﬁcantly increased to many folds (P< 0.05) (Fig. 4). In
FLS with IL-1 stimulation, adding HMW-HA decreased the
gene expression levels in most of the 16 genes. Among
these, adding HMW-HA signiﬁcantly decreased the aggre-
canase-2 gene expression level to 33% (P< 0.05)
[Fig. 6(B)]. Moreover, in the absence of HMW-HA, the
TNF-a gene expression level signiﬁcantly increased after
IL-1 stimulation (P< 0.05) (Fig. 4), however, in the pres-
ence of HMW-HA, it did not signiﬁcantly increase after
IL-1 stimulation. In other words, adding HMW-HA made
the increase of TNF-a gene expression induced by IL-1
stimulation become insigniﬁcant.
CD44 blocking inhibited the down-regulatory effects
of HMW-HA on gene expression
In FLS with IL-1 stimulation, pretreatment with anti-CD44
blocking mAb 5F12 inhibited the down-regulation of aggre-
canase-2, TNF-a, IL-8, and iNOS gene expression caused
by HMW-HA. However, pretreatment with isotype-matched
control IgG had no effect on the down-regulation of gene ex-
pression caused by HMW-HA (Fig. 7).
1243Osteoarthritis and Cartilage Vol. 14, No. 12Fig. 5. Dose-response study of the effect of HMW-HA (10 mg/ml, 100 mg/ml, and 1 mg/ml) on gene expression in FLS. (A) Effect of HMW-HA
on gene expression in FLS without IL-1 stimulation. Values are expressed in fold in comparison with control group after normalization to
housekeeping gene. (B) Effect of HMW-HA on gene expression in FLS with IL-1 (1 ng/ml) stimulation. Values are expressed in fold in com-
parison with IL-1 group after normalization to housekeeping gene. Data are expressed as mean S.E.M.Discussion
This study showed that HMW-HA can down-regulate the
gene expression of aggrecanase-2, TNF-a, IL-8, and iNOS
in synovial ﬂuid-derived FLS from the patients with early
stage OA. HMW-HA down-regulated the gene expression
of IL-8 and iNOS in unstimulated FLS and down-regulated
the gene expression of aggrecanase-2 and TNF-a inIL-1-stimulated FLS. These ﬁndings, to our knowledge,
have never been reported by other researchers.
We found that HMW-HA down-regulated the gene ex-
pression of aggrecanase-2 in IL-1-stimulated FLS. Aggreca-
nase-2 has been identiﬁed to be the primary aggrecanase
responsible for aggrecan degradation in a murine model
of OA27. Thus, down-regulation of aggrecanase-2 suggests
that HMW-HA may have a structure-modifying effect. We
1244 C.-T. Wang et al.: HA decreases cytokine and enzyme in FLSFig. 6. Effect of HMW-HA (100 mg/ml) on gene expression in FLS. (A) Effect of HMW-HA on gene expression in FLS without IL-1 stimulation.
Values are expressed in fold in comparison with control group after normalization to housekeeping gene. (B) Effect of HMW-HA on gene
expression in FLS with IL-1 (1 ng/ml) stimulation. Values are expressed in fold in comparison with IL-1 group after normalization to housekeep-
ing gene. Data are expressed as mean S.E.M. *P< 0.05. **There was signiﬁcant difference between IL-1 group and control group (Fig. 4), but
there was no signiﬁcant difference between ‘‘IL-1þHMW-HA’’ group and control group.also found that HMW-HA down-regulated the gene expres-
sion of iNOS, TNF-a, and IL-8 in FLS. In the literature, iNOS
is detected in OA synovium, suggesting that increased local
production of NO may contribute to the pathogenesis of in-
ﬂammatory arthritis by increasing synovial blood ﬂow and
by modulating cellular function within the synovium28. NOalso inhibits matrix synthesis in cartilage29. TNF-a is
a pro-inﬂammatory cytokine that plays key roles in altering
cartilage extracellular matrix turnover30. IL-8 is a cytokine
that may play a regulatory function in the inﬂammatory
process in OA31. Down-regulation of these inﬂammatory medi-
ators suggests that HMW-HA may have an anti-inﬂammatory
1245Osteoarthritis and Cartilage Vol. 14, No. 12effect. In addition, we observed that HMW-HA also de-
creased the gene expression of MMPs and other OA-asso-
ciated cytokines in FLS, although not in a signiﬁcant way.
Therefore, based on these results, it may be reasonable
to propose the use of HMW-HA in both inﬂammatory and
non-inﬂammatory status for OA patients, because in the
inﬂammatory status, HMW-HA could down-regulate aggre-
canase-2 and TNF-a, while in the non-inﬂammatory
status, HMW-HA could down-regulate IL-8 and iNOS in
FLS and thus prevent inﬂammation and destruction of
cartilage.
In the present study, we observed that the pretreatment of
FLS with anti-pan CD44 blocking mAb 5F12 could reverse
the down-regulatory effects of HMW-HA on the gene expres-
sion of aggrecanase-2, TNF-a, IL-8, and iNOS. This ﬁnding
suggests that the suppressive effects of HMW-HA on OA-
associated cytokines and enzymes in FLS are mediated
through the interaction of CD44 and HMW-HA, which is con-
sistent with the ﬁnding of Shimizu et al. in rheumatoid syno-
vial cells32. Similar suppressive effect of HMW-HA is also
found in chondrocytes. Julovi et al. found that HMW-HA
effectively inhibited IL-1b-stimulated production of MMP-1,
MMP-3, and MMP-13 in human articular cartilage explant,
which may involve direct interaction between HA and
CD44 on chondrocytes33. Tanaka et al. also showed that
HMW-HA suppressed MMP-1 and regulated on activation,
normal T expressed and secreted (RANTES) production in
chondrocytes via CD44eHA interaction34. However, how
HMW-HA interacts with CD44 remains undisclosed. Further
studies are needed to elucidate the CD44eHA signaling
pathway in OA synoviocytes.
Our results demonstrated that in FLS with IL-1 stimulation,
CD44 blocking only partially inhibited the down-regulatory
effects of HMW-HA on gene expression. This ﬁnding implies
that in addition to interacting with CD44, there may be an-
other mechanism for the observed inhibitory effects of HA
in this system. It is possible that the HA ‘‘traps’’ the IL-1 in
solution and so prevents IL-1 binding to its receptor.
Fig. 7. Effect of CD44 blocking on gene expression in FLS. FLS
were stimulated with IL-1 (1 ng/ml) and treated with HMW-HA
(100 mg/ml) with or without pretreatment with anti-CD44 blocking
mAb 5F12 (20 mg/ml) or isotype-matched control IgG (20 mg/ml).
Values are expressed in fold in comparison with IL-1 group after
normalization to housekeeping gene.We obtained synovial ﬂuid-derived FLS as the source of
RNA for RT-PCR in this study. Although there are many re-
searches studying FLS in OA patients, most of the FLS
were derived from the traditional synovium taken from the
surgical specimens of total joint arthroplasty. This means
that these FLS are derived from the synovium of the pa-
tients with advanced stage OA because only such patients
require total joint arthroplasty. Therefore, these cell models
only represent the FLS of advanced OA, so they may be
inappropriate to study the pathophysiologic mechanisms
of FLS in the progression of OA. It may be more logical to
use the synovial tissue obtained from non-arthroplastic joint
surgery of patients with early stage OA. This kind of sur-
gery, however, is few. In a recent research, the FLS ob-
tained from synovial ﬂuid are shown to be phenotypically
and functionally the same as those derived from the syno-
vium of surgical specimens12. This makes it possible to
study the FLS from the patients with early stage arthritis,
whose tissue specimens are seldom available, and also al-
lows longitudinal studies to determine whether or not the
function of FLS is altered by the disease course and by ther-
apy. We used this new cell model in studying the effects of
HMW-HA on synoviocytes and thus can infer the situation in
the patients with early stage OA, who are appropriate can-
didates to receive HMW-HA treatment, from the results of
this study17.
The current knowledge of the biology of FLS shows that
the intriguing functional property of FLS may stem from their
resemblance to bone marrow stromal cells: both cell types
share common progenitors and display similar gene expres-
sion proﬁles. It is therefore likely that, similar to the bone
marrow stromal cells, FLS may support or modulate the
effector character of resident or blood-derived cells in the
arthritic joint35e37. Moreover, responses to cytokines in
culture and in situ hybridization studies in diseased tissue
suggest that FLS secrete MMPs more readily than other
ﬁbroblasts38,39. Since the characteristics of FLS are
somewhat different from those of other ﬁbroblasts, it is un-
certain whether the data presented in our study could be
obtained with primary cultures of ﬁbroblasts from other
sources. It will be of interest to investigate the effects of
HMW-HA on other ﬁbroblasts, such as skin ﬁbroblasts, to
explore the therapeutic potential of HMW-HA in other
diseases.
In summary, we applied the real-time Q-PCR assays with
SYBR Green dye, which were specially designed for simul-
taneous quantiﬁcation of the gene expression of the 16 OA-
associated cytokines and enzymes with high sensitivity and
speciﬁcity, in synovial ﬂuid-derived FLS from the patients
with early stage OA. Our results suggest that HMW-HA
may have a structure-modifying effect for OA by down-reg-
ulation of the gene expression of aggrecanase-2 in FLS.
HMW-HA also has an anti-inﬂammatory effect by down-reg-
ulation of the gene expression of TNF-a, IL-8, and iNOS in
FLS. These effects may be mediated through the interaction
of CD44 and HMW-HA. Further studies are needed to elu-
cidate the molecular mechanism of the suppressive effects
of HMW-HA on these cytokines and enzymes in OA
synoviocytes.
Acknowledgments
This work was supported by Research Grants from the
National Science Council and the National Taiwan University
Hospital (NTUH 91-N009).
1246 C.-T. Wang et al.: HA decreases cytokine and enzyme in FLSReferences
1. Attur MG, Dave M, Akamatsu M, Katoh M, Amin AR.
Osteoarthritis or osteoarthrosis: the deﬁnition of
inﬂammation becomes a semantic issue in the geno-
mic era of molecular medicine. Osteoarthritis Cartilage
2002;10(1):1e4.
2. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoar-
thritis, an inﬂammatory disease: potential implication
for the selection of new therapeutic targets. Arthritis
Rheum 2001;44(6):1237e47.
3. Malemud CJ, Islam N, Haqqi TM. Pathophysiological
mechanisms in osteoarthritis lead to novel therapeutic
strategies. Cells Tissues Organs 2003;174(1e2):
34e48.
4. Pelletier JP, McCollum R, Cloutier JM, Martel-
Pelletier J. Synthesis of metalloproteases and interleu-
kin 6 (IL-6) in human osteoarthritic synovial membrane
is an IL-1 mediated process. J Rheumatol Suppl 1995;
43:109e14.
5. Borderie D, Hilliquin P, Hernvann A, Lemarechal H,
Kahan A, Menkes CJ, et al. Inhibition of inducible
NO synthase by TH2 cytokines and TGF beta in rheu-
matoid arthritic synoviocytes: effects on nitrosothiol
production. Nitric Oxide 2002;6(3):271e82.
6. Distler JH, Jungel A, Huber LC, Seemayer CA,
Reich CF 3rd, Gay RE, et al. The induction of matrix
metalloproteinase and cytokine expression in synovial
ﬁbroblasts stimulated with immune cell microparticles.
Proc Natl Acad Sci U S A 2005;102(8):2892e7.
7. Garcia-Vicuna R, Gomez-Gaviro MV, Dominguez-
Luis MJ, Pec MK, Gonzalez-Alvaro I, Alvaro-
Gracia JM, et al. CC and CXC chemokine receptors
mediate migration, proliferation, and matrix metallo-
proteinase production by ﬁbroblast-like synoviocytes
from rheumatoid arthritis patients. Arthritis Rheum
2004;50(12):3866e77.
8. Haupt JL, Frisbie DD, McIlwraith CW, Robbins PD,
Ghivizzani S, Evans CH, et al. Dual transduction of
insulin-like growth factor-I and interleukin-1 receptor
antagonist protein controls cartilage degradation in
an osteoarthritic culture model. J Orthop Res 2005;
23(1):118e26.
9. Ohta S, Harigai M, Tanaka M, Kawaguchi Y, Sugiura T,
Takagi K, et al. Tumor necrosis factor-alpha (TNF-
alpha) converting enzyme contributes to production
of TNF-alpha in synovial tissues from patients with
rheumatoid arthritis. J Rheumatol 2001;28(8):1756e63.
10. Yamanishi Y, Boyle DL, Clark M, Maki RA,
Tortorella MD, Arner EC, et al. Expression and regula-
tion of aggrecanase in arthritis: the role of TGF-beta.
J Immunol 2002;168(3):1405e12.
11. Lotz M, Moats T, Villiger PM. Leukemia inhibitory factor
is expressed in cartilage and synovium and can con-
tribute to the pathogenesis of arthritis. J Clin Invest
1992;90(3):888e96.
12. Stebulis JA, Rossetti RG, Atez FJ, Zurier RB. Fibro-
blast-like synovial cells derived from synovial ﬂuid.
J Rheumatol 2005;32(2):301e6.
13. Knudson CB, Knudson W. Hyaluronan and CD44: mod-
ulators of chondrocyte metabolism. Clin Orthop 2004;
(427 Suppl):S152e62.
14. Nagano O, Saya H. Mechanism and biological signiﬁ-
cance of CD44 cleavage. Cancer Sci 2004;95(12):
930e5.
15. Laurent TC, Fraser JR. Hyaluronan. FASEB J 1992;
6(7):2397e404.16. Balazs EA, Watson D, Duff IF, Roseman S. Hyaluronic
acid in synovial ﬂuid. I. Molecular parameters of
hyaluronic acid in normal and arthritis human ﬂuids.
Arthritis Rheum 1967;10(4):357e76.
17. Wang CT, Lin J, Chang CJ, Lin YT, Hou SM. Therapeu-
tic effects of hyaluronic acid on osteoarthritis of the
knee. A meta-analysis of randomized controlled trials.
J Bone Joint Surg Am 2004;86-A(3):538e45.
18. Qiu B, Liu SQ, Peng H, Wang HB. The effects of sodium
hyaluronate on mRNA expressions of matrix metallo-
proteinase-1, -3 and tissue inhibitor of metalloprotei-
nase-1 in cartilage and synovium of traumatic
osteoarthritis model. Chin J Traumatol 2005;8(1):8e12.
19. Sasaki A, Sasaki K, Konttinen YT, Santavirta S,
Takahara M, Takei H, et al. Hyaluronate inhibits the
interleukin-1beta-induced expression of matrix metal-
loproteinase (MMP)-1 and MMP-3 in human synovial
cells. Tohoku J Exp Med 2004;204(2):99e107.
20. Takahashi K, Goomer RS, Harwood F, Kubo T,
Hirasawa Y, Amiel D. The effects of hyaluronan on
matrix metalloproteinase-3 (MMP-3), interleukin-1beta
(IL-1beta), and tissue inhibitor of metalloproteinase-1
(TIMP-1)geneexpressionduring thedevelopment ofos-
teoarthritis. Osteoarthritis Cartilage 1999;7(2):182e90.
21. Wilhelm J, Pingoud A. Real-time polymerase chain re-
action. Chembiochem 2003;4(11):1120e8.
22. Ponchel F, Toomes C, Bransﬁeld K, Leong FT,
Douglas SH, Field SL, et al. Real-time PCR based
on SYBR-Green I ﬂuorescence: an alternative to the
TaqMan assay for a relative quantiﬁcation of gene
rearrangements, gene ampliﬁcations and micro gene
deletions. BMC Biotechnol 2003;3(1):18.
23. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ.
Basic local alignment search tool. J Mol Biol 1990;
215(3):403e10.
24. Whelan JA, Russell NB, Whelan MA. A method for the
absolute quantiﬁcation of cDNA using real-time PCR.
J Immunol Methods 2003;278(1e2):261e9.
25. Ovstebo R, Haug KB, Lande K, Kierulf P. PCR-based
calibration curves for studies of quantitative gene
expression in human monocytes: development and
evaluation. Clin Chem 2003;49(3):425e32.
26. Pfafﬂ MW, Horgan GW, Dempﬂe L. Relative expression
software tool (REST) for group-wise comparison and
statistical analysis of relative expression results in
real-time PCR. Nucleic Acids Res 2002;30(9):e36.
27. Glasson SS, Askew R, Sheppard B, Carito B,
Blanchet T, Ma HL, et al. Deletion of active ADAMTS5
prevents cartilage degradation in a murine model of
osteoarthritis. Nature 2005;434(7033):644e8.
28. Grabowski PS, Wright PK, Van ’t Hof RJ, Helfrich MH,
Ohshima H, Ralston SH. Immunolocalization of induc-
ible nitric oxide synthase in synovium and cartilage in
rheumatoid arthritis and osteoarthritis. Br J Rheumatol
1997;36(6):651e5.
29. Studer R, Jaffurs D, Stefanovic-Racic M, Robbins PD,
Evans CH. Nitric oxide in osteoarthritis. Osteoarthritis
Cartilage 1999;7(4):377e9.
30. Westacott CI, Barakat AF, Wood L, Perry MJ, Neison P,
Bisbinas I, et al. Tumor necrosis factor alpha can
contribute to focal loss of cartilage in osteoarthritis.
Osteoarthritis Cartilage 2000;8(3):213e21.
31. Goldring MB. The role of cytokines as inﬂammatory me-
diators in osteoarthritis: lessons from animal models.
Connect Tissue Res 1999;40(1):1e11.
32. Shimizu M, Yasuda T, Nakagawa T, Yamashita E,
Julovi SM, Hiramitsu T, et al. Hyaluronan inhibits
1247Osteoarthritis and Cartilage Vol. 14, No. 12matrix metalloproteinase-1 production by rheumatoid
synovial ﬁbroblasts stimulated by proinﬂammatory
cytokines. J Rheumatol 2003;30(6):1164e72.
33. Julovi SM, Yasuda T, Shimizu M, Hiramitsu T,
Nakamura T. Inhibition of interleukin-1beta-stimulated
production of matrix metalloproteinases by hyaluronan
via CD44 in human articular cartilage. Arthritis Rheum
2004;50(2):516e25.
34. Tanaka M, Masuko-Hongo K, Kato T, Nishioka K,
Nakamura H. Suppressive effects of hyaluronan on
MMP-1 and RANTES production from chondrocytes.
Rheumatol Int 2006;26(3):185e90.
35. Edwards JC. Fibroblast biology. Development and dif-
ferentiation of synovial ﬁbroblasts in arthritis. Arthritis
Res 2000;2(5):344e7.36. Kontoyiannis D, Kollias G. Fibroblast biology. Synovial
ﬁbroblasts in rheumatoid arthritis: leading role or cho-
rus line? Arthritis Res 2000;2(5):342e3.
37. Ritchlin C. Fibroblast biology. Effector signals released
by the synovial ﬁbroblast in arthritis. Arthritis Res
2000;2(5):356e60.
38. Goldring MB, Krane SM. Modulation by recombinant
interleukin 1 of synthesis of types I and III collagens
and associated procollagen mRNA levels in cultured
human cells. J Biol Chem 1987;262(34):16724e9.
39. Gravallese EM, Darling JM, Ladd AL, Katz JN,
Glimcher LH. In situ hybridization studies of stromely-
sin and collagenase messenger RNA expression in
rheumatoid synovium. Arthritis Rheum 1991;34(9):
1076e84.
